1. Home
  2. LDWY vs NLSP Comparison

LDWY vs NLSP Comparison

Compare LDWY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LDWY
  • NLSP
  • Stock Information
  • Founded
  • LDWY 1990
  • NLSP 2015
  • Country
  • LDWY United States
  • NLSP Switzerland
  • Employees
  • LDWY N/A
  • NLSP N/A
  • Industry
  • LDWY Advertising
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LDWY Consumer Discretionary
  • NLSP Health Care
  • Exchange
  • LDWY Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • LDWY 9.2M
  • NLSP 8.2M
  • IPO Year
  • LDWY 1991
  • NLSP 2021
  • Fundamental
  • Price
  • LDWY $4.50
  • NLSP $0.21
  • Analyst Decision
  • LDWY
  • NLSP Hold
  • Analyst Count
  • LDWY 0
  • NLSP 1
  • Target Price
  • LDWY N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • LDWY 3.6K
  • NLSP 26.8M
  • Earning Date
  • LDWY 08-08-2024
  • NLSP 07-30-2024
  • Dividend Yield
  • LDWY N/A
  • NLSP N/A
  • EPS Growth
  • LDWY N/A
  • NLSP N/A
  • EPS
  • LDWY N/A
  • NLSP N/A
  • Revenue
  • LDWY $14,244,000.00
  • NLSP N/A
  • Revenue This Year
  • LDWY N/A
  • NLSP N/A
  • Revenue Next Year
  • LDWY N/A
  • NLSP N/A
  • P/E Ratio
  • LDWY N/A
  • NLSP N/A
  • Revenue Growth
  • LDWY 337.74
  • NLSP N/A
  • 52 Week Low
  • LDWY $3.72
  • NLSP $0.11
  • 52 Week High
  • LDWY $8.15
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • LDWY 43.91
  • NLSP 56.71
  • Support Level
  • LDWY $4.43
  • NLSP $0.19
  • Resistance Level
  • LDWY $4.62
  • NLSP $0.22
  • Average True Range (ATR)
  • LDWY 0.08
  • NLSP 0.04
  • MACD
  • LDWY 0.04
  • NLSP 0.00
  • Stochastic Oscillator
  • LDWY 24.97
  • NLSP 16.67

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: